Erdal Cavusoglu

Summary

Publications

  1. doi Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, Bronx Veterans Affairs Medical Center, NY, USA
    Am J Med 124:724-30. 2011
  2. doi Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patients referred for coronary angiography
    Erdal Cavusoglu
    Department of Medicine, State University of New York Health Science Center, Brooklyn, New York, USA
    Am J Cardiol 101:1073-8. 2008
  3. ncbi Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 1257, Brooklyn, NY 11203 2098, USA
    Arterioscler Thromb Vasc Biol 27:929-35. 2007
  4. ncbi Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 100:164-8. 2007
  5. ncbi Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203 2098, USA
    J Am Coll Cardiol 50:1768-76. 2007
  6. ncbi Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiography
    Erdal Cavusoglu
    Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 100:1739-43. 2007
  7. doi Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA
    Int J Cardiol 141:141-6. 2010
  8. doi Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York 11203 2098, USA
    Coron Artery Dis 20:112-7. 2009
  9. doi Relation of baseline serum potassium levels to angiographic findings in patients with known or suspected coronary artery disease
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Hypertens 22:754-62. 2009
  10. doi Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography
    Erdal Cavusoglu
    Department of Medicine, Division of Cardiology, SUNY Downstate Medical Center, Brooklyn, NY 11203 2098, United States
    Atherosclerosis 207:261-5. 2009

Collaborators

Detail Information

Publications46

  1. doi Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, Bronx Veterans Affairs Medical Center, NY, USA
    Am J Med 124:724-30. 2011
    ..The objective of the present study was to investigate the long-term prognostic significance of baseline IL-10 levels in patients with acute coronary syndrome...
  2. doi Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patients referred for coronary angiography
    Erdal Cavusoglu
    Department of Medicine, State University of New York Health Science Center, Brooklyn, New York, USA
    Am J Cardiol 101:1073-8. 2008
    ..52, 95% confidence interval 1.15 to 2.02, p = 0.0034). In conclusion, baseline plasma adiponectin was an independent predictor of LV systolic dysfunction in a population of patients referred for coronary angiography...
  3. ncbi Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 1257, Brooklyn, NY 11203 2098, USA
    Arterioscler Thromb Vasc Biol 27:929-35. 2007
    ..RANTES is a chemokine produced by a variety of cell types including platelets that has been implicated in atherosclerosis...
  4. ncbi Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 100:164-8. 2007
    ..In conclusion, in a cohort of men across a spectrum of risk referred for coronary angiography, a single baseline determination of serum complement C4 level is an independent predictor of the future development of stroke...
  5. ncbi Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203 2098, USA
    J Am Coll Cardiol 50:1768-76. 2007
    ..The purpose of this study was to determine the association of the F11 receptor (F11R) with human vascular disease...
  6. ncbi Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiography
    Erdal Cavusoglu
    Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 100:1739-43. 2007
    ..In conclusion, these data demonstrate that low baseline levels of total choline-containing phospholipid are a strong and independent predictor of cardiovascular outcomes (including mortality) in patients with acute coronary syndromes...
  7. doi Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA
    Int J Cardiol 141:141-6. 2010
    ..However, there are no data in other cardiac populations, including patients with acute coronary syndromes (ACS)...
  8. doi Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York 11203 2098, USA
    Coron Artery Dis 20:112-7. 2009
    ..However, there are very limited data in patients with acute coronary syndromes (ACS)...
  9. doi Relation of baseline serum potassium levels to angiographic findings in patients with known or suspected coronary artery disease
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Hypertens 22:754-62. 2009
    ..The objective of this study was to determine the association between plasma potassium levels and angiographically defined coronary artery disease (CAD)...
  10. doi Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography
    Erdal Cavusoglu
    Department of Medicine, Division of Cardiology, SUNY Downstate Medical Center, Brooklyn, NY 11203 2098, United States
    Atherosclerosis 207:261-5. 2009
    ..39, 95% CI 1.18-4.86, p=0.0161 and OR 1.41, 95% CI 1.05-1.89, p=0.0206, respectively). In conclusion, PLTP activity may represent a novel marker of LV systolic dysfunction in patients with known or suspected coronary artery disease...
  11. ncbi Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography
    Erdal Cavusoglu
    Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 98:1189-93. 2006
    ....
  12. doi Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, United States
    Atherosclerosis 210:226-31. 2010
    ..High baseline plasma levels of ADMA in patients with DM have been shown to predict diabetes related complications. However, there are limited data on the prognostic significance of baseline ADMA levels in patients with established DM...
  13. ncbi The use of clopidogrel in patients with coronary artery disease
    Erdal Cavusoglu
    Interventional Cardiology SUNY Downstate Medical Center, Brooklyn, New York 11203 2098, USA
    Anadolu Kardiyol Derg 4:63-72. 2004
    ..This article focuses on clopidogrel, an antiplatelet agent belonging to the class of drugs known as the thienopyridines, in the treatment of patients with coronary artery disease...
  14. ncbi Clopidogrel in the management of ischemic heart disease
    Erdal Cavusoglu
    Department of Medicine, Bronx VA Medical Center, Bronx, NY 10468, USA
    Heart Dis 5:144-52. 2003
    ..Therefore, despite improved outcomes, further studies are required to determine the optimal duration and dosage regimen of such combination therapy to maximize its risk-benefit ratio...
  15. ncbi Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 99:1364-8. 2007
    ..34 ng/ml was 88% compared with 74% in those whose values were >20.34 ng/ml (p = 0.0249 by log-rank test). In conclusion, these data demonstrate that baseline MPO levels independently predict MI at 2 years in patients with ACS...
  16. ncbi Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 1257, Brooklyn, NY 11203 2098, USA
    Eur Heart J 27:2300-9. 2006
    ..To determine the prognostic value of baseline plasma adiponectin levels in patients with known or suspected coronary artery disease referred for coronary angiography...
  17. doi Long-term mortality after bolus-only administration of abciximab, eptifibatide, or tirofiban during percutaneous coronary intervention
    Jonathan D Marmur
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA
    Catheter Cardiovasc Interv 73:214-21. 2009
    ..To evaluate the long-term mortality after bolus-only administration of abciximab, eptifibatide, and tirofiban during percutaneous coronary intervention (PCI)...
  18. ncbi Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction
    Erdal Cavusoglu
    Department of Medicine, State University of New York Health Science Center, Brooklyn, NY 11203 2098, USA
    Am Heart J 151:1101.e1-8. 2006
    ..The prognostic value of plasma tissue inhibitor of metalloproteinase-1 (TIMP-1) levels in patients with established or suspected coronary artery disease is unknown...
  19. ncbi Bolus-only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention
    Jonathan D Marmur
    State University of New York, SUNY Downstate Medical Center, Brooklyn, New York, USA
    J Invasive Cardiol 18:521-6. 2006
    ....
  20. ncbi Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 98:580-4. 2006
    ..0065 by log-rank test). In conclusion, these data demonstrate that baseline anemia is a strong and independent predictor of death or AMI at 2 years in patients with ACS...
  21. ncbi Activated clotting time (ACT)-guided intravenous dalteparin dosing during percutaneous coronary intervention
    Jonathan D Marmur
    Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, New York, USA
    J Invasive Cardiol 20:323-7. 2008
    ..The activated clotting time (ACT) has been reported to be sensitive to the anticoagulant activity of the low-molecular weight heparin dalteparin following intravenous (IV) administration...
  22. ncbi Impact of body mass index on long-term all-cause mortality after percutaneous coronary intervention in African-Americans
    Shyam Poludasu
    Cardiology, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA
    J Invasive Cardiol 21:20-5. 2009
    ..Hypothesis. We assessed the hypothesis that BMI is an independent predictor of post-PCI long-term mortality in African-Americans...
  23. ncbi Effects of alcoholism on coronary artery disease and left ventricular dysfunction in male veterans
    Spyros Kokolis
    S U N Y Downstate Medical Center, Brooklyn, New York, USA
    J Invasive Cardiol 18:304-7. 2006
    ..The objective of this study was to compare coronary anatomy and left ventricular dysfunction in patients with and without alcoholism associated with heavy consumption...
  24. doi All-cause mortality after drug-eluting stent implantation in African-Americans
    Shyam Poludasu
    Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, New York 11203 2098, USA
    Coron Artery Dis 19:551-7. 2008
    ..The effect of drug-eluting stents on mortality in African-Americans is unknown...
  25. ncbi Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin
    Sunil X Anand
    The Zena and Michael A Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA
    Am J Cardiol 100:417-24. 2007
    ..These data suggest that bivalirudin and UFH may confer an anti-inflammatory effect by reducing sCD40L during PCI...
  26. doi Effect of hemoglobin level on long-term all-cause mortality after percutaneous coronary intervention in African-Americans
    Shyam Poludasu
    Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, USA
    Am J Cardiol 103:1078-82. 2009
    ..6 for group with Hgb > or =11.1 to <12.7 compared with the group with the highest Hgb value). In conclusion, baseline Hgb is a strong and independent predictor of all-cause long-term mortality in African-Americans undergoing PCI...
  27. doi Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of inflamed vascular smooth muscle cells and in atherosclerosis
    Bani M Azari
    Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY 11203 2098, USA
    Atherosclerosis 212:197-205. 2010
    ..Here we report our investigation of the expression of F11R in atherosclerotic arteries of coronary artery disease (CAD) patients, and of the role of F11R in the migration of SMCs involved in atherogenesis...
  28. ncbi High-dose tirofiban administered as bolus-only during percutaneous coronary intervention
    Jonathan D Marmur
    SUNY Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 1257, Brooklyn, NY, 11203 2098, USA
    J Invasive Cardiol 20:53-8. 2008
    ....
  29. ncbi Impact of gender on in-hospital percutaneous coronary interventional outcomes in African-Americans
    Shyam Poludasu
    Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, New York, USA
    J Invasive Cardiol 19:123-8. 2007
    ..The impact of gender on post-PCI outcomes in African-Americans has not been reported...
  30. doi Neutrophil to lymphocyte ratio as a predictor of long-term mortality in African Americans undergoing percutaneous coronary intervention
    Shyam Poludasu
    Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, New York, USA
    Clin Cardiol 32:E6-E10. 2009
    ..African Americans have been shown to have lower mean neutrophil counts compared to whites. The usefulness of the N/L ratio in predicting long-term mortality in African Americans undergoing PCI is unknown...
  31. ncbi A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory
    Jonathan D Marmur
    Department of Cardiology, SUNY Health Sciences Center at Brooklyn, 450 Clarkson Avenue, Box 1257, Brooklyn, NY 11203, USA
    J Invasive Cardiol 20:449-54. 2008
    ....
  32. ncbi Avoiding intelligence failures in the cardiac catheterization laboratory: Strategies for the safe and rational use of dalteparin or enoxaparin during percutaneous coronary intervention
    Jonathan D Marmur
    Department of Medicine, State University of New York Health Science Center at Brooklyn, 11203 2098, USA
    J Invasive Cardiol 21:653-64. 2009
    ....
  33. ncbi Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial
    Jonathan D Marmur
    Division of Cardiology, Department of Medicine, State University of New York Health Science Center at Brooklyn, NY 11203 2098, USA
    Am Heart J 152:876-81. 2006
    ....
  34. doi Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention
    Shyam Poludasu
    Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY 11203 2098, USA
    Thromb Haemost 102:581-7. 2009
    ..7, HR for death in patients with high RDW relative to low RDW was 8.6 (CI:2.8-28.6). Higher RDW was a strong and independent predictor of long-term mortality in patients undergoing PCI who were not anaemic at baseline...
  35. ncbi Very late bare-metal stent thrombosis. A case report and review of the literature
    Nagarathna Manjappa
    Interventional Cardiology Division, SUNY Downstate Medical Center, Brooklyn, New York, USA
    J Invasive Cardiol 18:E203-6. 2006
    ..We report a case of very late thrombosis of a bare-metal stent occurring 717 days after implantation...
  36. ncbi The activated clotting time (ACT) can be used to monitor enoxaparin and dalteparin after intravenous administration
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, the Bronx Veterans Administration Medical Center, Bronx, NY, USA
    J Invasive Cardiol 17:416-21. 2005
    ..The use of low-molecular weight heparin (LMWH) during percutaneous coronary intervention (PCI) has been limited by the presumed inability to monitor its anticoagulant effect using bedside assays...
  37. ncbi Current status of rotational atherectomy
    Erdal Cavusoglu
    Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA
    Catheter Cardiovasc Interv 62:485-98. 2004
    ..Recommendations are also made for its use in the current interventional era...
  38. ncbi Percutaneous coronary intervention in a patient with congenital factor XI deficiency and acquired inhibitor
    Sudhir Mungee
    Division of Cardiology, SUNY Downstate Medical Center, Brooklyn, NY 11203 2098, USA
    Cardiology 107:69-72. 2007
    ..Immunosuppressive therapy, plasma exchange and factor VII product transfusions have been used prior to cardiac interventions in few such reported cases...
  39. ncbi Beyond lipid lowering: the anti-hypertensive role of statins
    Vineet Chopra
    Division of Internal Medicine, Bronx Veterans Affairs Medical Center and the Mount Sinai School of Medicine, Bronx, NY, USA
    Cardiovasc Drugs Ther 21:161-9. 2007
    ....
  40. pmc MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humans
    Ming Zhang
    Department of Anesthesiology, State University of New York Downstate Medical Center, Brooklyn, NY, USA
    Int J Cardiol 166:499-504. 2013
    ..We investigated the role of MASP-2 in human acute myocardial ischemia in two clinical settings: (1) Acute MI, and (2) Open heart surgery...
  41. ncbi Contrast-associated nephropathy
    Vikas R Soma
    Department of Medicine, Bronx VA Medical Center, Bronx, New York, USA
    Heart Dis 4:372-9. 2002
    ..The growing use of these new agents, such as acetylcysteine, endothelin blockers, and most recently fenoldopam, has increased the options available for the prevention of CaN...
  42. ncbi Direct thrombin inhibitor use during percutaneous coronary intervention
    Spyros Kokolis
    State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203, USA
    J Cardiovasc Pharmacol 45:270-9. 2005
    ..We review the pharmacological properties of these newer antithrombotic agents and evaluate the clinical data demonstrating their use in patients undergoing PCI...
  43. ncbi Catheter-induced spasm of the left main coronary artery due to anatomic "kinking" in its course
    Umesh S Lingegowda
    Division of Cardiology, Department of Medicine, SUNY, Downstate Medical Center, Box 1199, 450 Clarkson Avenue, Brooklyn, NY, 11203, USA
    J Invasive Cardiol 17:192-4. 2005
  44. ncbi The use of the glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary intervention
    Jonathan D Marmur
    Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA
    J Interv Cardiol 15:71-84. 2002
    ..Finally, evidence indicates that the majority of patients with acute coronary syndromes without ST segment elevation who are scheduled to undergo PCI should be pretreated with a GPIIb/IIIa receptor antagonist...
  45. ncbi Twiddler's syndrome: an interesting cause of pacemaker failure
    Ricardo Castillo
    Section of Cardiology, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA
    Cardiology 105:119-21. 2006
    ..This report underscores the importance of dementia as a risk factor for twiddler's syndrome...
  46. ncbi Anticoagulation strategies for patients undergoing percutaneous coronary intervention: unfractionated heparin, low-molecular-weight heparins, and direct thrombin inhibitors
    Spyros Kokolis
    State University of New York, Health Science Center at Brooklyn, 11203, USA
    Prog Cardiovasc Dis 46:506-23. 2004
    ..This paper reviews the pharmacologic properties of these newer antithrombotic agents and evaluates the clinical data demonstrating their use in patients undergoing PCI...